N-[2-[1-[4-amino-3-(3-fluoro-5-hydroxyphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]ethyl]indolizin-3-yl]-N-propylacetamide

C26H26FN7O2 — CID 149474081

IUPACN-[2-[1-[4-amino-3-(3-fluoro-5-hydroxyphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]ethyl]indolizin-3-yl]-N-propylacetamide
SMILESCCCN(C(C)=O)c1c(C(C)n2nc(-c3cc(O)cc(F)c3)c3c(N)ncnc32)cc2ccccn12
InChIInChI=1S/C26H26FN7O2/c1-4-8-32(16(3)35)26-21(13-19-7-5-6-9-33(19)26)15(2)34-25-22(24(28)29-14-30-25)23(31-34)17-10-18(27)12-20(36)11-17/h5-7,9-15,36H,4,8H2,1-3H3,(H2,28,29,30)
InChIKeyZBYAHMRUSRJURD-UHFFFAOYSA-N
MW487.54 g/mol
LogP4.55
Rot. Bonds6

About N-[2-[1-[4-amino-3-(3-fluoro-5-hydroxyphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]ethyl]indolizin-3-yl]-N-propylacetamide

N-[2-[1-[4-amino-3-(3-fluoro-5-hydroxyphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]ethyl]indolizin-3-yl]-N-propylacetamide (PubChem CID 149474081) has the molecular formula C26H26FN7O2 and a molecular weight of 487.54 g/mol. Its IUPAC name is N-[2-[1-[4-amino-3-(3-fluoro-5-hydroxyphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]ethyl]indolizin-3-yl]-N-propylacetamide.

Molecular Properties

Compound NameN-[2-[1-[4-amino-3-(3-fluoro-5-hydroxyphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]ethyl]indolizin-3-yl]-N-propylacetamide
PubChem CID149474081
Molecular FormulaC26H26FN7O2
Molecular Weight487.54 g/mol
Exact Mass487.21
IUPAC NameN-[2-[1-[4-amino-3-(3-fluoro-5-hydroxyphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]ethyl]indolizin-3-yl]-N-propylacetamide
SMILESCCCN(C(C)=O)c1c(C(C)n2nc(-c3cc(O)cc(F)c3)c3c(N)ncnc32)cc2ccccn12
InChIInChI=1S/C26H26FN7O2/c1-4-8-32(16(3)35)26-21(13-19-7-5-6-9-33(19)26)15(2)34-25-22(24(28)29-14-30-25)23(31-34)17-10-18(27)12-20(36)11-17/h5-7,9-15,36H,4,8H2,1-3H3,(H2,28,29,30)
InChIKeyZBYAHMRUSRJURD-UHFFFAOYSA-N
XLogP4.55
TPSA114.57 Ų
H-Bond Donors2
H-Bond Acceptors8
Rotatable Bonds6
Heavy Atoms36
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500487.54
LogP ≤ 54.55
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 108

Analyze N-[2-[1-[4-amino-3-(3-fluoro-5-hydroxyphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]ethyl]indolizin-3-yl]-N-propylacetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[2-[1-[4-amino-3-(3-fluoro-5-hydroxyphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]ethyl]indolizin-3-yl]-N-propylacetamide?
The IUPAC name of N-[2-[1-[4-amino-3-(3-fluoro-5-hydroxyphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]ethyl]indolizin-3-yl]-N-propylacetamide (CID 149474081) is N-[2-[1-[4-amino-3-(3-fluoro-5-hydroxyphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]ethyl]indolizin-3-yl]-N-propylacetamide.
What is the SMILES notation for N-[2-[1-[4-amino-3-(3-fluoro-5-hydroxyphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]ethyl]indolizin-3-yl]-N-propylacetamide?
The canonical SMILES for N-[2-[1-[4-amino-3-(3-fluoro-5-hydroxyphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]ethyl]indolizin-3-yl]-N-propylacetamide is CCCN(C(C)=O)c1c(C(C)n2nc(-c3cc(O)cc(F)c3)c3c(N)ncnc32)cc2ccccn12.
What is the InChIKey of N-[2-[1-[4-amino-3-(3-fluoro-5-hydroxyphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]ethyl]indolizin-3-yl]-N-propylacetamide?
The InChIKey is ZBYAHMRUSRJURD-UHFFFAOYSA-N. The full InChI is InChI=1S/C26H26FN7O2/c1-4-8-32(16(3)35)26-21(13-19-7-5-6-9-33(19)26)15(2)34-25-22(24(28)29-14-30-25)23(31-34)17-10-18(27)12-20(36)11-17/h5-7,9-15,36H,4,8H2,1-3H3,(H2,28,29,30).
What are the key properties of N-[2-[1-[4-amino-3-(3-fluoro-5-hydroxyphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]ethyl]indolizin-3-yl]-N-propylacetamide?
N-[2-[1-[4-amino-3-(3-fluoro-5-hydroxyphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]ethyl]indolizin-3-yl]-N-propylacetamide has a molecular weight of 487.54 g/mol, XLogP of 4.55, 6 rotatable bonds, 2 hydrogen bond donors, and 8 hydrogen bond acceptors.
Where does this data come from?
All data for N-[2-[1-[4-amino-3-(3-fluoro-5-hydroxyphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]ethyl]indolizin-3-yl]-N-propylacetamide is sourced from PubChem (CID 149474081), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).